Two Sigma Advisers’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,107
Closed -$51.8K 2489
2024
Q4
$51.8K Buy
5,107
+3,027
+146% +$30.7K ﹤0.01% 2279
2024
Q3
$25.9K Buy
+2,080
New +$25.9K ﹤0.01% 2244
2024
Q1
Sell
-4,213
Closed -$54.7K 2553
2023
Q4
$54.7K Buy
4,213
+1,866
+80% +$24.2K ﹤0.01% 2394
2023
Q3
$47.2K Sell
2,347
-15,000
-86% -$301K ﹤0.01% 2280
2023
Q2
$466K Sell
17,347
-9,420
-35% -$253K ﹤0.01% 1833
2023
Q1
$1.56M Sell
26,767
-20,113
-43% -$1.17M ﹤0.01% 1402
2022
Q4
$2.39M Sell
46,880
-8,540
-15% -$436K 0.01% 1138
2022
Q3
$4.54M Sell
55,420
-10,313
-16% -$845K 0.01% 778
2022
Q2
$4.45M Buy
65,733
+14,046
+27% +$950K 0.01% 827
2022
Q1
$5.71M Buy
51,687
+23,180
+81% +$2.56M 0.02% 749
2021
Q4
$2.75M Sell
28,507
-43,626
-60% -$4.21M 0.01% 1036
2021
Q3
$6.3M Buy
72,133
+6,640
+10% +$580K 0.02% 688
2021
Q2
$10.1M Buy
65,493
+4,813
+8% +$745K 0.03% 558
2021
Q1
$9.58M Buy
60,680
+26,887
+80% +$4.24M 0.03% 589
2020
Q4
$7.85M Sell
33,793
-45,267
-57% -$10.5M 0.02% 653
2020
Q3
$17.3M Buy
79,060
+18,827
+31% +$4.12M 0.05% 358
2020
Q2
$17.1M Buy
60,233
+11,426
+23% +$3.25M 0.05% 369
2020
Q1
$14.1M Buy
48,807
+13,860
+40% +$3.99M 0.05% 375
2019
Q4
$10M Buy
34,947
+21,380
+158% +$6.15M 0.02% 599
2019
Q3
$1.96M Sell
13,567
-6,186
-31% -$893K ﹤0.01% 1121
2019
Q2
$1.78M Sell
19,753
-4,954
-20% -$445K ﹤0.01% 1262
2019
Q1
$2.16M Buy
24,707
+9,140
+59% +$801K 0.01% 1186
2018
Q4
$2.19M Sell
15,567
-326
-2% -$45.8K 0.01% 1137
2018
Q3
$4.06M Buy
15,893
+5,460
+52% +$1.39M 0.01% 908
2018
Q2
$2.66M Buy
+10,433
New +$2.66M 0.01% 1169